Sign up to save your podcasts
Or
Share Genotype-Guided vs. Conventional P2Y12 Inhibitors in ACS | JACC: CV Interventions | JACC: Cardiovascular Interventions
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Genotype-Guided vs. Conventional P2Y12 Inhibitors in ACS | JACC: CV Interventions | JACC: Cardiovascular Interventions
Mirza Umair Khalid, MD, Social Media Editor for JACC: Cardiovascular Interventions, and Mattio Galli, MD, PhD, discuss a recently published original research paper analyzing the role of genotype-guided escalation or de-escalation of antiplatelet therapy in acute coronary syndrome (ACS).
View all episodes
By American College of Cardiology
3.8
1919 ratings
Mirza Umair Khalid, MD, Social Media Editor for JACC: Cardiovascular Interventions, and Mattio Galli, MD, PhD, discuss a recently published original research paper analyzing the role of genotype-guided escalation or de-escalation of antiplatelet therapy in acute coronary syndrome (ACS).
More shows like JACC Specialty Journals
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
319 Listeners
JAMA Clinical Reviews
502 Listeners
JACC This Week
162 Listeners
This Week in Cardiology
890 Listeners
Mayo Clinic Talks
297 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
137 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
Annals On Call Podcast
199 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
521 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
371 Listeners
Cardionerds: A Cardiology Podcast
433 Listeners
The Curious Clinicians
377 Listeners